Related Experiment Video
Updated: Aug 17, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Deep venous thrombosis prophylaxis in patients with heart disease
1Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA. shivelyb@ohsu.edu
Abstract:
Therapy to prevent deep venous thrombosis (DVT) and pulmonary embolism remains essential for inpatients, despite short periods of bedrest and hospitalization. Although most available data pertain to surgical patients, subgroups of medical patients are at moderate, high, and very high risk for DVT. These include patients admitted to the medical intensive care unit, those with the acute coronary syndromes, and those with congestive heart failure. Patients with unstable angina and acute myocardial infarction usually receive anticoagulation for other indications. However, for most patients with congestive heart failure (who will be at bedrest initially), DVT prophylaxis may be the only indication for anticoagulation. Recommended regimens are 5000 units of unfractionated heparin subcutaneously every 8 hours or enoxaparin 40 mg subcutaneously daily.
Related Concept Videos
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system as it...
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management

